Prosperity Bancshares, Inc (PB) Stock News

Prosperity Bancshares is highlighted as an attractive dividend stock with a 3.39% yield, significantly higher than the industry average of 1.53%. The company has increased its dividend 5 times over the last 5 years with an average annual increase of 4.50%, and expects solid earnings growth of 13.71% in 2026. With a Zacks Rank of #2 (Buy) and a conservative 40% payout ratio, PB represents a compelling investment opportunity for income investors.

OP Bancorp (OPBK) is highlighted as an attractive dividend investment opportunity for income investors. The company offers a 3.74% dividend yield, significantly higher than industry and S&P 500 averages, with a 16.7% year-over-year dividend increase. With a solid 29% payout ratio and expected 19.77% earnings growth for 2026, OPBK receives a Zacks Rank #2 (Buy) rating.

Prestige Consumer Healthcare (PBH) is a Zacks Rank #2 (Buy) stock benefiting from strategic acquisitions of Breathe Right and LaCorium Health, expected to add nearly 20% to its revenue base and lift fiscal 2027 guidance to $1.29-$1.315 billion. The company's e-commerce channel has grown to 18% of net sales with double-digit growth momentum. However, elevated debt levels ($2.0 billion net debt) and foreign exchange exposure pose risks to profitability.

Wall Street analysts expect Campbell to report Q4 earnings of $0.40 per share, representing a 35.5% year-over-year decline, with revenues projected at $2.15 billion, down 7.3%. The consensus EPS estimate has been revised 2.4% lower over the past 30 days. Both the Meals & Beverages and Snacks segments are expected to show significant declines in operating earnings compared to the prior year.

Ken Burns and PBS LearningMedia announced the launch of 'Ken Burns in the Classroom' on YouTube, bringing free, curriculum-aligned educational content to teachers and students. The initiative begins with three courses focused on The American Revolution, featuring professionally edited film segments and interactive materials. Additional courses from Burns's extensive filmography will follow in coming weeks.

The article compares two biotech ETFs from Invesco: IBBQ, which offers broad diversification across 251 companies with a low 0.19% expense ratio, and PBE, which takes a concentrated approach with 31 holdings and a higher 1.73% dividend yield. IBBQ is recommended for long-term investors seeking low-cost exposure, while PBE appeals to income-focused investors willing to pay higher fees for selective, momentum-driven picks.

The Vanguard Health Care ETF (VHT) offers broad healthcare exposure with a low 0.09% expense ratio and 423 holdings, while the Invesco Biotechnology & Genome ETF (PBE) provides focused biotech exposure with 31 holdings and higher growth potential. PBE delivered a stronger 40.88% one-year return but experienced greater volatility with a 37.84% maximum drawdown, while VHT returned 27.85% with lower risk. VHT suits conservative investors seeking steady, low-cost exposure, while PBE appeals to risk-tolerant investors chasing biotech innovation.

The article compares two unprofitable but rapidly growing companies: Planet Labs PBC, which operates 200+ satellites for Earth imaging, and Snowflake, a cloud data platform for AI analytics. Both face different competitive pressures and risk profiles. Planet Labs has lower valuation multiples but higher government revenue concentration, while Snowflake benefits from platform-agnostic positioning in the AI boom. The author gives a slight edge to Planet Labs for its stronger competitive moat, though neither is guaranteed long-term success.

Northrim BanCorp announced it will acquire PBCO Financial Corporation (People's Bank of Commerce) in an all-stock transaction valued at approximately $167.3 million ($32.36 per share). The merger marks Northrim's first out-of-state expansion, extending its community banking operations into Southern Oregon and the Willamette Valley. The combined entity will have over $4 billion in assets, with closing expected in Q4 2026 or early Q1 2027.

PBF Energy stock rose 10.5% this week and is up nearly 125% in 2026, driven by widening crack spreads (the difference between refined product prices and crude oil prices). The increase is fueled by geopolitical tensions in the Strait of Hormuz following the collapse of a memorandum of understanding with Iran, which restricts commercial traffic and reduces global refined product supply. This benefits PBF as a U.S. refiner that can access domestic crude while profiting from higher margins on refined products.

PBF Energy stock rose 10.6% this week following deterioration in US-Iran relations and ceasefire breakdown. The stock gained despite rising oil prices because the crack spread (difference between refined product prices and input costs) widened significantly. Supply disruptions from potential Strait of Hormuz closure benefit domestic refiners like PBF by increasing refined product prices relative to crude oil costs.

Prestige Consumer Healthcare (PBH) shares dropped over 11% on May 14, 2026, after the company reported significant revenue declines and production problems at its recently acquired Pillar5 facility. The facility, which was supposed to resolve Clear Eyes supply chain constraints, failed to deliver expected results. Q4 2026 revenues fell 5% year-over-year, with North America OTC Eye & Ear Care declining 20.6%. Hagens Berman has opened an investigation into whether the company adequately disclosed these issues to investors.

The article compares two consumer staples ETFs: XLP (State Street Consumer Staples Select Sector SPDR ETF) and PBJ (Invesco Food & Beverage ETF). XLP offers a broader consumer staples exposure with a significantly lower expense ratio (0.08% vs 0.61%), higher dividend yield (2.6% vs 1.6%), and superior 5-year performance ($1,344 vs $1,174 on $1,000 invested). PBJ focuses narrowly on food and beverage stocks with a more concentrated portfolio. Both are defensive investments with low volatility, but XLP emerges as the stronger choice for most investors due to its cost efficiency, higher returns, and larger asset base.

Pomerantz LLP is investigating potential securities fraud claims against Prestige Consumer Healthcare Inc. following the company's May 13, 2026 earnings announcement that revealed a 4.5% organic revenue decline and production issues with Clear Eyes products. The stock fell 11.35% to $45.93 per share on May 14, 2026, prompting the investigation into whether company officers and directors engaged in unlawful business practices.

Ipsen announced late-breaking results from the ELATIVE Phase III trial and real-world studies showing IQIRVO (elafibranor) demonstrated clinically meaningful improvements in fatigue, with 67% of patients achieving improvement versus 31% on placebo at Week 52. Real-world data showed 59% of patients achieved ALP normalization at 6 months, and the Phase IV ELFINITY study confirmed rapid ALP reductions and favorable tolerability in routine clinical practice.

Marpai Inc. announced a historic expansion with 192,000 new estimated member lives across its TPA and MarpaiRx PBM platforms, representing a nearly six-fold increase. The company expects to achieve positive cash flow and positive EBITDA beginning August 2026, with rollouts scheduled between August 2026 and January 2027.

The global Purpose Built Backup Appliance (PBBA) market is projected to grow from USD 8.67 billion in 2025 to USD 22.0 billion by 2035, driven by rising ransomware threats, increased enterprise data volumes, and regulatory compliance requirements. The market is experiencing rapid growth across North America and Europe, with Asia Pacific emerging as the fastest-growing region. Hardware components and open systems dominate the market, while services are expected to grow fastest.